| Tislelizumab |
替雷利珠单抗 |
1858168-59-8 |
| V-9302 |
V-9302 |
1855871-76-9 |
| METHYL 3-(TRIMETHYLSILYL)-4-PENTENOATE |
3-(三甲基硅烷基)-4-戊烯酸甲酯 |
185411-12-5 |
| Tibulizumab |
Tibulizumab |
1849636-24-3 |
| ALC-0159 |
甲氧基聚乙二醇双十四烷基乙酰胺 |
1849616-42-7 |
| DO-34 (DO34) |
DO-34 (DO34) |
1848233-58-8 |
| Nafoxidine |
盐酸萘福昔定 |
1847-63-8 |
| Nafoxidine |
萘福昔定 |
1845-11-0 |
| PF-06821497 |
PF-06821497 |
1844849-10-0 |
| 7-bromochroman-4-one |
7-溴-4-二氢色原酮 |
18442-22-3 |
| Zilucoplan |
ZILUCOPLAN |
1841136-73-9 |
| CIPROXIFAN |
环丙基[4-[3-(1H-咪唑-4-基)丙氧基]苯基]甲酮马来酸盐 |
184025-19-2 |
| Formoterol fumarate dihydrate |
富马酸福莫特罗二水合物 |
183814-30-4 |
| N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-(2,2,2-trifluoroethyl)-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide |
BEFOTERTINIB |
1835667-63-4 |
| 2-Propenamide, N-[2-[2-(dimethylamino)ethoxy]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]- |
REZIVERTINIB |
1835667-12-3 |
| Dersimelagon |
Dersimelagon |
1835256-48-8 |
| Fmoc-Ala-Ala-Asn(Trt)-PAB |
ALA-ALA-ASN(TRT)-PAB |
1834515-99-9 |
| 5-METHOXY-1H-PYRROLO[2,3-B]PYRIDINE |
5-甲氧基-7-氮杂吲哚 |
183208-36-8 |
| DDP-38003 (dihydrochloride) |
DDP 38003 DIHYDROCHLORIDE; DDP38003 DIHYDROCHLORIDE |
1831167-98-6 |
| iJak-381 |
IJAK-381 |
1831144-46-7 |
QQ
微信
